Insilico, a biotech firm, showcases a new AI-driven drug discovery for lung diseases amidst its third Hong Kong IPO attempt. Founded in 2014 at Johns Hopkins University, Insilico is now based in Boston, with operations in mainland China and Hong Kong. With a lab in Suzhou and an office at Science Park, the company is […]
Category: boston biotech
Defence Therapeutics Establishes US Laboratory in Biotech Hub
1 Defence Therapeutics has announced the opening of a new laboratory in the Boston-Cambridge biotech hub, marking a significant milestone in the company’s expansion efforts. This strategic move positions Defence Therapeutics to leverage the resources and expertise available in one of the leading biotech clusters in the United States. By establishing a presence in this […]
Key Biotech News: Lyra’s Success, Sanofi’s Acquisition
In the latest biotech updates, Lyra Therapeutics celebrates a significant achievement while Sanofi makes a notable acquisition. These developments highlight the dynamic nature of the biotech industry in Boston, a hub for groundbreaking research and innovation. With biotech jobs on the rise in Massachusetts, the challenges of hiring skilled professionals remain a key focus for […]
iTeos Biotech Closure Impacts Cancer Therapeutics Sector
iTeos, a Watertown-based biotech company, announced its shutdown, mirroring a trend in the industry. This decision coincided with Keros Therapeutics’ discontinuation of a high blood pressure drug candidate, resulting in substantial layoffs. With Keros reducing its workforce by 45%, the aftermath leaves the company with only 85 employees, highlighting the challenges faced by biotech firms […]
Advances in Lung Disease Treatment by Insilico Medicine
Insilico Medicine, an AI drug startup, has made significant progress in treating lung disease. The study, although promising, had inconclusive data on certain metrics. It involved 71 patients in China over a 12-week period. Some patients experienced worsening conditions and liver injury, which will be closely monitored in future trials. Despite these side effects, Insilico […]
